ACCL (ACCL) Stock Price & Analysis
ACCL (ACCL) rose 0.47% to USD 2.13 as of July 25, 2026 at 05:32 UTC, according to Nexqual real-time market data.
ACCL last closed at USD 2.12; the session ranged USD 2.12–2.28 on volume of 66,221 shares. Market capitalization is $29.71M, with a 52-week range of USD 1.23–5 (NCM). Source: Nexqual, July 25, 2026 at 05:32 UTC.
Key Statistics (as of July 25, 2026 at 05:32 UTC)
| Price | USD 2.13 |
|---|---|
| Change | ▲ 0.47% (up) |
| Previous Close | USD 2.12 |
| Open | USD 2.2 |
| Day Range | USD 2.12 – 2.28 |
| 52-Week Range | USD 1.23 – 5 |
| Volume | 66,221 shares |
| Market Cap | $29.71M |
| Exchange | NCM |
Technical Analysis (ACCL)
Nexqual's technical model rates ACCL "BUY" based on 5 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 05:32 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 72.8 (overbought) |
| vs SMA50 | Above (USD 1.66) |
| MACD | 0.12 (positive) |
Analyst Ratings (ACCL)
Wall Street analysts rate ACCL "None", per Nexqual as of July 25, 2026 at 05:32 UTC.
| Consensus Rating | None |
|---|
Earnings (ACCL)
Source: Nexqual, July 25, 2026 at 05:32 UTC.
Financials & Fundamentals (ACCL)
| Total Revenue | $4.92M |
|---|---|
| Revenue Growth (YoY) | +1.00% |
| Gross Margin | +41.69% |
| Operating Margin | +2.70% |
| Profit Margin | +11.28% |
| ROE | +14.80% |
| Debt / Equity | 3.7 |
| Current Ratio | 4.22 |
| Total Cash | $6.40M |
| Total Debt | $213,948 |
| Free Cash Flow | $727,427 |
Source: Nexqual, July 25, 2026 at 05:32 UTC.
Financial Health Score (ACCL)
Nexqual rates ACCL's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 05:32 UTC.
| Growth | Mixed — Revenue +1.0% YoY (latest Q), slow |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Strong — $6M cash, no debt |
| Cash Flow | Solid — FCF $727K, 15% margin |
| Efficiency | Mixed — ROE 15%, ROA 6.6% |
Ownership (ACCL)
| Insider Ownership | +92.16% |
|---|---|
| Institutional Ownership | +0.13% |
| Shares Outstanding | 13.95M |
| Float | 2.94M |
| Short % of Float | +2.21% |
Source: Nexqual, July 25, 2026 at 05:32 UTC.
Leadership (ACCL)
ACCL is led by Cheung Po Lui (age 44), CEO & Director, per Nexqual as of July 25, 2026 at 05:32 UTC.
| CEO & Director | Cheung Po Lui (age 44) |
|---|---|
| CFO & Chairman | Yuen Yuk Hau (age 43) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SLSN | Solesence, Inc. | USD 0.94 | ▲ 10.59% |
| SKYE | Skye Bioscience, Inc. | USD 0.65 | ▲ 1.88% |
| NVEC | NVE Corporation | USD 117.55 | ▲ 35.61% |
| ALTI | AlTi Global, Inc. | USD 3.41 | ▲ 2.1% |
| VECO | Veeco Instruments Inc. | USD 51.66 | ▼ 5.38% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 05:32 UTC. This page is informational and not investment advice.